This edition of the Vinge Life Sciences Report, which is published annually, summarises some of the legislative reforms and regulatory developments that have shaped the sector over the past year, as well as other selected topics of interest.
Vinge's Life Sciences Report 2025 includes:
Vinge’s Life Sciences Report 2025 for download
Europe’s life sciences sector is being reshaped by ambitious investment and policy momentum, exemplified by the European Commission’s strategy to make Europe the world’s most attractive hub for life sciences by 2030. At the same time, the regulatory climate has tightened, with evolving legal frameworks for pharmaceuticals and medical devices, as well as for the use of data and AI systems.
Drawing on extensive experience, deep sector insight and Vinge’s full-service business law offering, Vinge’s Life Sciences Practice Group helps clients navigate rapid change with whatever expertise needed. We translate complex, shifting rules into clear, practical strategies – turning regulatory pressure into competitive advantage.
Vinge’s Life Sciences offer spans not only core life sciences areas – such as pharmaceuticals, biotechnology, and medical devices – but also adjacent sectors. These include cosmetics, veterinary and animal health, food, beverages, and alcohol, as well as related industries like chemicals, nutrition, healthcare services, and digital health. This broad scope enables the firm to support clients across the full spectrum of regulated products and innovations.
Our advice is based on many years’ experience, which we can tailor to suit each client’s needs. Clients value our combination of substantial legal expertise and experience of the industry when they need to make and implement business decisions.
